Lake Superior Centre For Regenerative MedicineSeptember 12, 2025

FDA 483 - Lake Superior Centre For Regenerative Medicine - September 12, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Lake Superior Centre For Regenerative Medicine

Record Details

Lake Superior Centre For Regenerative Medicine, a tissue processor in Thunder Bay, was cited for five observations related to inadequate process validation, insufficient procedures to prevent communicable disease transmission, and poor facility maintenance. The inspection revealed significant deficiencies in aseptic processing controls and environmental cleanliness, increasing the risk of contamination for human bone grafts. These issues indicate a failure to ensure the safety and quality of distributed HCT/Ps.

Company: Lake Superior Centre For Regenerative Medicine
Inspection Date: September 12, 2025
Product Type: Biologics
Office: International Compliance Team
Person: Emily A. Walters (issuing_officer)

Open in Dashboard

ID · 2d148a5b-dab9-4cdf-8dbc-d5af83c1796f